Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Feasibility, Acceptability, and Preliminary Efficacy of a Group Reminiscence Intervention in a Sample of Inpatients With Schizophrenia

NCT07512843 is registered in ClinicalTrials.gov with The Hashemite University as lead sponsor.

NCT NCT07512843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07512843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Feasibility, Acceptability, and Preliminary Efficacy of a Group Reminiscence Intervention in a Sample of Inpatients With Schizophrenia
Lead sponsor
The Hashemite University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2025
Completion date
December 28, 2025
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospitalized adult patients, schizophrenia 1 (disorder), schizophrenia cognition autobiographical memory cognitive remediation